THL – TorHoerman Law

Hospitals’ Plan to Combat Big Pharma’s Generic Drugs Problem: If You Can’t be ‘Em, Join ‘Em

 

Big Pharma’s monopoly over the generic drugs industry has for years been cause for concern for U.S. hospital systems, which frequently deal with drug scarcity and manipulation of drug prices brought on by the pharmaceutical industry. Now, some Read More »

The Opioid Epidemic: Addressing Our Nation’s Biggest Health Threat

 

Do you think opioid addiction is becoming an epidemic? Between 2010 and 2016, opioid addiction increased by an outstanding amount – 493%, according to a study conducted by Blue Cross Blue Shield of its members. According to new research, opioid ad Read More »

Addiction to Opioids Epidemic Fueled by $46M in Payouts to Physicians?

 

According to a study released in the American Journal of Public Health earlier this month, 68,177 American physicians received payouts totaling more than $46 million from prescription opioid manufacturers from 2013 to 2015. Drug overdose has become t Read More »

AstraZeneca’s Farxiga Safety Claims Contradict FDA Findings

 

Last month at the American Diabetes Association’s (ADA) 77th Scientific Sessions, AstraZeneca Plc. presented new data supporting the safety and effectiveness of their SLGT-2 inhibitor Farxiga. This data is in direct contention with the FDA̵ Read More »

Questionable Drug Safety Reporting System FAERS

 

 According to a report by the Institute for Safe Medication Practices (ISMP), the FDA’s Adverse Event Reporting System (FAERS) is flawed and needs modernization. ISMP’s report is based on the analysis of 847,039 reports gathered over Read More »

Pharmaceutical Marketing: How Drug Ads Influence Health Care

 

Today, drug companies spend $4 billion a year on ads to consumers. In 1997, the FDA rules governing pharmaceutical advertising changed, and now companies can name both the drug and what it’s for, while only naming the most significant potential Read More »

Filter News

No-Obligation Free Consultation

Contact us by phone at 1-888-508-6752 or email us below.

Sidebar Contact